Mobileye Global Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Mobileye Global Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Revenue	967	1,386	1,869	2,079	1,654	1,894
Cost of revenue	591	731	947	1,032	913	990
Gross profit	376	655	922	1,047	741	904
Research and development	440	544	789	889	1,083	1,151
Selling and marketing	116	134	120	118	118	113
General and administrative	33	34	50	73	70	80
Operating expenses	589	712	959	1,080	3,966	1,344
Operating income	-213	-57	-37	-33	-3,225	-440
Interest expense			24
Other non-operating income	-5	-3	11	49	62
Pre-tax income	-212	-57	-32	16	-3,163	-377
Income tax	-16	18	50	43	-73	15
Net income	-196	-75	-82	-27	-3,090	-392
EBITDA	-200	-40	-14	6	-3,163	-366
EPS, basic	-0.26	-0.10	-0.11	-0.03	-3.82	-0.48
EPS, diluted	-0.26	-0.10	-0.11	-0.03	-3.82	-0.48
Shares, basic (weighted)	0	750	759	805	809	813
Shares, diluted (weighted)	0	750	759	805	809	813

Balance sheet

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	93	616	1,024	1,212	1,426	1,836
Short-term investments				932	984	1,071
Receivables		155	269	357	212	131
Inventory		97	113	391	415	327
Other current assets		76	110	106	121	129
Total current assets		2,270	1,516	2,066	2,174	2,478
Property, plant and equipment		304	384	447	458	473
Lease right-of-use assets		21	57	49	47	50
Goodwill		10,895	10,895	10,895	8,200	8,200
Intangible assets		3,071	2,527	2,053	1,609	1,166
Other non-current assets		115	119	116	138	175
Total assets		16,655	15,441	15,577	12,579	12,492
Accounts payable		160	73	39	4	4
Accrued liabilities		102	88	87	105	141
Total current liabilities		474	384	403	333	406
Lease liabilities		12	45	39	37	44
Other non-current liabilities		17	45	46	50	67
Total liabilities		766	647	653	492	611
Paid-in capital			14,737	14,886	15,137	15,308
Retained earnings			57	30	-3,060	-3,452
Other comprehensive income		5	-9		2	17
Shareholders' equity	15,842	15,889	14,794	14,924	12,087	11,881
Total equity	15,842	15,889	14,794	14,924	12,087	11,881
Total liabilities and equity		16,655	15,441	15,577	12,579	12,492
Shares outstanding			51.9	94.7

Cash flow statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Net income	-196	-75	-82	-27	-3,090	-392
Depreciation and amortization	13	17	23	39	62	74
Stock-based compensation	85	97	174	252	279	277
Deferred income tax	-53	-29	-17	-15	-101	-15
Change in receivables	7	-62	-114	-88	124	81
Change in inventory	-25	31	-16	-278	-24	89
Change in payables	-14	59	58	10	-29	26
Cash from operations	271	599	546	394	400	602
Capital expenditures	-91	-143	-111	-98	-81	-79
Acquisitions	-745
Purchases of investments					-62	-106
Sales and maturities of investments					23	94
Cash from investing	-965	-157	1,187	-98	-120	-91
Share buybacks						-100
Dividends paid	0	0	-337	0	0
Cash from financing	732	91	-1,317	-100	-66	-106
Exchange rate effect		-1	-6	-5	-2	17
Net change in cash	38	532	410	191	212	422
Free cash flow	180	456	435	296	319	523
Income taxes paid	-42	-44	-57	64	21	11

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $8.03 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	47.4%	Gross profit / revenue.
Operating margin	-207.1%	Operating income / revenue.
EBITDA margin	-203.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-204.2%	Pre-tax income / revenue.
Net margin	-201.5%	Net income / revenue.
FCF margin	19.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.3%	Cash from operations / revenue.
Return on equity (ROE)	-49.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-46.0%	Net income / average total assets.
Return on invested capital (ROIC)	-47.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	55.8%	Research and development expense / revenue.
Stock-based pay / revenue	15.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	4.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	14.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	22.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	19.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	50.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	3.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	17.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	63.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	6.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	23.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-1.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-7.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-5.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1,511.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.60x	Current assets / current liabilities.
Quick ratio	3.36x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.90x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	7.1%	Total liabilities / total assets.
Working capital	$1.63B	Current assets - current liabilities.
Goodwill and intangibles / assets	67.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.23B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.23x	Revenue / average total assets.
Fixed asset turnover	4.27x	Revenue / average property, plant and equipment.
Inventory turnover	3.42x	Cost of revenue / average inventory.
Days inventory	107 days	365 x average inventory / cost of revenue.
Receivables turnover	9.69x	Revenue / average receivables.
Days sales outstanding	38 days	365 x average receivables / revenue.
Days payables	1 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	144 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	20.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$4.97	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.46	Revenue / diluted weighted shares.
FCF per share	$0.47	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.60	Cash from operations / diluted weighted shares.
Book value per share	$10.04	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.73	Tangible book value / shares outstanding.
Cash per share	$1.60	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$6.83B	Share price x shares outstanding.
Enterprise value	$5.52B	Market cap + total debt - cash - short-term investments.
P/S	3.39x	Market cap / revenue.
P/B	0.83x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.06x	Market cap / tangible book value, when positive.
P/FCF	17.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.9x	Market cap / cash from operations, when positive.
EV/Sales	2.74x	Enterprise value / revenue.
EV/FCF	14.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.7%	Free cash flow / market cap.
Earnings yield	-59.5%	Net income / market cap (the inverse of P/E).

What was Mobileye Global Inc.'s revenue in fiscal 2025?

Mobileye Global Inc. reported revenue of $1.89B for fiscal 2025, 14.5% higher than the year before.

Was Mobileye Global Inc. profitable in fiscal 2025?

No. It reported a net loss of $392.0M.

How much free cash flow did Mobileye Global Inc. generate in fiscal 2025?

Cash from operations of $602.0M minus capital expenditures of $79.0M left free cash flow of $523.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Mobileye Global Inc.